Large-scale testing (Phase 3)Study completedNCT00971542
What this trial is testing
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
Who this might be right for
Pandemic Influenza
Novartis Vaccines 778